Osteoblastoma Response to Chemotherapy
Overview
Affiliations
An 8-year-old boy had an osteoblastoma of the body of C2. After attempted excision, the tumor recurred rapidly and massively. The tumor shrank progressively after treatment with high-dose methotrexate, doxorubicin, and cisplatin. The patient has stopped treatment and been stable for 33 months. Surgical excision remains the treatment of choice for osteoblastoma. Chemotherapy may be useful in selected patients with a recurrent, aggressive tumor or in patients with surgically inaccessible disease.
Mandibular Osteoblastoma: A Case Report of a Rare Entity.
Skariah P G, S S, Valsaraj K, Shahana S, Basha S, Pathak A Cureus. 2024; 16(2):e53900.
PMID: 38465192 PMC: 10924824. DOI: 10.7759/cureus.53900.
Neoadjuvant denosumab for the treatment of a sacral osteoblastoma.
Reynolds J, Rothenfluh D, Athanasou N, Wilson S, Kieser D Eur Spine J. 2018; 27(Suppl 3):446-452.
PMID: 29356985 DOI: 10.1007/s00586-018-5461-z.
Zhu Y, Min H, Fang J, Zhou F, Deng X, Zhang Y Cancer Biol Ther. 2015; 16(4):602-9.
PMID: 25869769 PMC: 4622008. DOI: 10.1080/15384047.2015.1017155.
Kumar Singh D, Das K, Mehrotra A, Srivastava A, Jaiswal A, Gupta P J Craniovertebr Junction Spine. 2014; 4(2):69-72.
PMID: 24744565 PMC: 3980559. DOI: 10.4103/0974-8237.128533.
Ying H, Wang Z, Zhang Y, Yang T, Ding Z, Liu S Mol Cell Biochem. 2013; 384(1-2):229-37.
PMID: 24005536 DOI: 10.1007/s11010-013-1802-8.